Trace Insider Trading in Intel, Pfizer, Gilead Sciences, General Electric, Exxon Mobil, and Walt Disney
HONG KONG, May 7, 2013 /PRNewswire/ -- Insiderslab.com has issued insider trading reports for the following companies: Intel (NASDAQ: INTC), Pfizer (NYSE: PFE), Gilead Sciences (NASDAQ: GILD), General Electric (NYSE: GE), Exxon Mobil (NYSE: XOM), and Walt Disney (NYSE: DIS).
(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)
Intel Corporation (NASDAQ: INTC): By the end of last trading session, the shares of Intel (NASDAQ: INTC) lost US$0.05 (or 0.21%) to US$23.91 with 31.01 million shares exchanged hands, compared to daily average volume of 51.19 million. The trading price ranged between US$23.85 and US$51.19. Insiderslab.com found company Exec VP, Dir Corp Stratgy, CFO, Stacy J. Smith, sold his shares at a price of US$24.05 for about US$2.16 million on May 3. The company recently promoted Brian Krzanich as its new CEO, which will be effective on May 16. Investors may want to find out how Intel insiders like CEOs, CFOs and Directors are thinking about the future of the company. Check this insider trade report for INTC here.
Read Full Report: http://www.insiderslab.com/PR3/050713A/INTC/Intel.pdf
Pfizer Inc. (NYSE: PFE): By the end of last trading session, Pfizer Inc. (NYSE: PFE) shares lost US$0.24 (or 0.83%) to US$28.72 with about 33.11 million shares exchanged hands for the session, compared to its average volume of 34.51 million shares. Insiderslab.com found company insiders sold his/her shares for about US$8.65 million in the first quarter. The company finally started selling Viagra on its website to compete with black market. "Viagra" was searched for nearly 24 million times per year. Investors may want to find out how Pfizer insiders like CEOs, CFOs and Directors are thinking about the future of the company.
Read Full Report: http://www.insiderslab.com/PR3/050713A/PFE/Pfizer.pdf
Gilead Sciences, Inc. (NASDAQ: GILD): By the end of last trading session, Gilead Sciences (NASDAQ: GILD) dropped US$0.72 (or 1.31%) to US$54.43 with about 13.33 million shares exchanged hands for the session, compared to its average volume of 12.95 million shares. Insiderslab.com found company Chairman and CEO, John C. Martin, sold his shares for about US$14.16 million on May 1. Last Friday, the shares reached its 52-week high of US$56.35. Insiderslab.com believes that it is a clever way to check if insiders like CEOs, CFOs, and Directors in Gilead Sciences are starting to buy more company shares. See insider trade report for GILD here.
Read Full Report: http://www.insiderslab.com/PR3/050713A/GILD/GileadSciences.pdf
Today Insiderslab.com also observed abnormal trade volume for the following companies; insiders may involve trading in these companies. It will take some time for insiders to report their trades. Read these reports and add these companies into your Insider Trade Radar.
General Electric Company (NYSE: GE):
Read Full Report: http://www.insiderslab.com/PR3/050713A/GE/GeneralElectric.pdf
Exxon Mobil Corporation (NYSE: XOM):
Read Full Report: http://www.insiderslab.com/PR3/050713A/XOM/ExxonMobil.pdf
The Walt Disney Company (NYSE: DIS):
Read Full Report: http://www.insiderslab.com/PR3/050713A/DIS/WaltDisney.pdf
Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.
Insiderslab.com covers insider trade data in major stock markets in the U.S., Hong Kong, Mainland China, and Singapore. Insiderslab.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.
Please visit insiderslab.com/disclaimers/disclaimers.php for details.
SOURCE Insiderslab.com; Insiders.hk
More by this Source
Stocks in the Spotlight for Shareholders of Facebook, Yahoo, American Capital Agency
Dec 09, 2013, 08:55 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.